Understand the source comparison
Pralmorelin: Peptide Comparison
Before selecting a growth hormone secretagogue for research, understanding the functional and pharmacokinetic differences between pralmorelin and related peptides is essential. The table below compares pralmorelin to other commonly studied GH secretagogues bas
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Before selecting a growth hormone secretagogue for research, understanding the functional and pharmacokinetic differences between pralmorelin and related peptides is essential. The table below compares pralmorelin to other commonly studied GH secretagogues based on receptor mechanism, half-life, and typical research endpoints.
- | Peptide | Receptor Mechanism | Half-Life | Peak GH Response (Time) | Primary Research Use | Notable Secondary Effects | Professional Assessment ||—|—|—|—|—|—|| Pralmorelin | GHS-R1a agonist (ghrelin receptor) | 25–30 minutes | 20–40 minutes | Diagnostic GH testing, acute body composition studies | Cortisol and prolactin elevation | Rapid-acting, short-duration secretagogue ideal for acute provocation testing; transient cortisol spike limits chronic use appeal || Ipamorelin | GHS-R1a agonist (selective) | ~2 hours | 30–60 minutes | Body composition, lean mass studies | Minimal cortisol/prolactin effect | More selective GHS-R1a agonist with lower HPA axis activation; preferred for protocols requiring repeated dosing || Sermorelin | GHRH receptor agonist | 10–20 minutes | 20–30 minutes | GH deficiency treatment, anti-aging protocols | Works synergistically with ghrelin agonists | Acts on a different receptor class (GHRH vs ghrelin); often combined with GHRP peptides for synergistic GH r